| Tretinoin | Approved Investigational Nutraceutical | GYG2 | 8908 |
downregulated | Tretinoin results in decreased expression of GYG2 mRNA | Xp22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GYPC | 2995 |
upregulated | Tretinoin results in increased expression of GYPC mRNA | 2q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | H19 | 283120 |
upregulated | Tretinoin results in increased expression of H19 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | H1F0 | 3005 |
upregulated | Tretinoin results in increased expression of H1F0 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | H1FX | 8971 |
upregulated | Tretinoin results in increased expression of H1FX mRNA | 3q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | H2AFX | 3014 |
downregulated | Tretinoin results in decreased expression of H2AFX mRNA | 11q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | H2BFS | 54145 |
downregulated | Tretinoin results in decreased expression of H2BFS mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | H3F3B | 3021 |
upregulated | Tretinoin results in increased expression of H3F3B mRNA | 17q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HAGLR | 401022 |
upregulated | Tretinoin results in increased expression of HAGLR mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HAND2-AS1 | 79804 |
upregulated | Tretinoin results in increased expression of HAND2-AS1 mRNA | 4q34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HAPLN1 | 1404 |
upregulated | Tretinoin results in increased expression of HAPLN1 mRNA | 5q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HAS2 | 3037 |
downregulated | Tretinoin results in decreased expression of HAS2 mRNA | 8q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HAS2 | 3037 |
upregulated | Tretinoin results in increased expression of HAS2 mRNA | 8q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HAS3 | 3038 |
downregulated | Tretinoin results in decreased expression of HAS3 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HAT1 | 8520 |
downregulated | Tretinoin results in decreased expression of HAT1 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HAUS1 | 115106 |
downregulated | Tretinoin results in decreased expression of HAUS1 mRNA | 18q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HBD | 3045 |
upregulated | Tretinoin results in increased expression of HBD mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | HBE1 | 3046 |
upregulated | Tretinoin results in increased expression of HBE1 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | HBEGF | 1839 |
upregulated | Tretinoin metabolite results in increased expression of HBEGF mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HBEGF | 1839 |
upregulated | Tretinoin results in increased expression of HBEGF mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HBP1 | 26959 |
upregulated | Tretinoin results in increased expression of HBP1 mRNA | 7q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HCK | 3055 |
upregulated | Tretinoin results in increased expression of HCK mRNA | 20q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | HCN3 | 57657 |
upregulated | Tretinoin results in increased expression of HCN3 mRNA | 1q22 | |
| Tretinoin | Approved Investigational Nutraceutical | HDAC1 | 3065 |
upregulated | Tretinoin results in increased expression of HDAC1 mRNA | 1p35.2-p35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HDAC11 | 79885 |
downregulated | Tretinoin results in decreased expression of HDAC11 mRNA | 3p25.1 | |